HomepageNB3 • FRA
add
Neurocrine Biosciences
Vorige slotkoers
€ 108,95
Dag-range
€ 108,80 - € 108,80
Jaar-range
€ 77,78 - € 147,45
Beurswaarde
12,78 mld. USD
Gem. volume
18,00
Koers/winst
-
Dividendrendement
-
Primaire beurs
NASDAQ
In het nieuws
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
| (USD) | mrt 2025info | Wijziging j-o-j |
|---|---|---|
Opbrengst | 572,60 mln. | 11,12% |
Bedrijfskosten | 276,50 mln. | 13,74% |
Netto inkomsten | 7,90 mln. | -81,80% |
Netto winstmarge | 1,38 | -83,61% |
Winst per aandeel | 0,70 | -41,67% |
EBITDA | 31,30 mln. | -71,93% |
Effectief belastingtarief | 46,26% | — |
Balans
Totale activa
Totale passiva
| (USD) | mrt 2025info | Wijziging j-o-j |
|---|---|---|
Contanten en kortetermijnbeleggingen | 943,50 mln. | -22,06% |
Totale activa | 3,69 mld. | 6,20% |
Totale passiva | 1,15 mld. | 6,05% |
Totaal aandelenvermogen | 2,54 mld. | — |
Uitstaande aandelen | 98,97 mln. | — |
Koers-boekwaardeverhouding | 4,25 | — |
Rendement op activa | 1,60% | — |
Rendement op kapitaal | 1,94% | — |
Kasstroom
Nettomutatie in liquide middelen
| (USD) | mrt 2025info | Wijziging j-o-j |
|---|---|---|
Netto inkomsten | 7,90 mln. | -81,80% |
Operationele kasstroom | 64,80 mln. | -50,27% |
Kasstroom uit beleggingen | 14,20 mln. | 125,82% |
Kasstroom uit financiering | -117,90 mln. | -268,67% |
Nettomutatie in liquide middelen | -38,90 mln. | -126,79% |
Vrije kasstroom | 28,91 mln. | -88,50% |
Over
Neurocrine Biosciences, Inc. is an American biopharmaceutical company founded in 1992. It is headquartered in San Diego, California, and led by CEO Kyle Gano as of October 11, 2024. Neurocrine develops treatments for neurological and endocrine-related diseases and disorders. In 2017, the company's drug valbenazine was approved in the US to treat adults with tardive dyskinesia.
The company is also developing treatments that are in various stages of clinical research for Parkinson's disease, Tourette syndrome, and congenital adrenal hyperplasia and with a partner for endometriosis and uterine fibroids. Wikipedia
Opgericht
1992
Hoofdvestiging
Website
Werknemers
1.800
